MAPs for PrEP

This qualitative assessment explored the usability, hypothetical acceptability and programmatic fit of microarray patches (MAPs) a new drug delivery system for PrEP in early-stage of product development. It was supported by PATH/USAID from 2018-2021
As a result, a Poster presentation at the INTEREST Conference 2020 was made with the findings and an article has been written as well.